176 results on '"Juran, Brian D."'
Search Results
2. A scalable workflow to characterize the human exposome
3. The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis
4. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
5. Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis
6. Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis
7. THU-135 Real-world study of reasons for non-utilization of second-line treatment in patients with primary biliary cholangitis
8. Su1486 GERMLINE VARIANTS OF CANCER-PREDISPOSITION GENES IN PATIENTS WITH PSC-IBD
9. Mo1604 REAL-WORLD STUDY TO EXAMINE BASELINE CHARACTERISTICS, CONCURRENT AUTOIMMUNE CONDITIONS AND ENVIRONMENTAL EXPOSURES AS POSSIBLE PREDICTORS OF RESPONSE TO URSODEOXYCHOLIC ACID FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS
10. Mo1590 RELIABILITY OF USING BINARY BIOCHEMICAL CRITERIA AT MONTH 6 FOR PREDICTING TREATMENT OUTCOMES IN PRIMARY BILIARY CHOLANGITIS
11. Variations in primary sclerosing cholangitis across the age spectrum
12. Questionnaire based assessment of risk factors for primary biliary cirrhosis
13. Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients
14. Genome-Wide Association Studies in Primary Biliary Cirrhosis
15. Primary biliary cirrhosis
16. High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.
17. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
18. Genetic insights into primary biliary cirrhosis - an international collaborative meta-analysis and replication study: 133
19. Environmental Factors in Primary Biliary Cirrhosis
20. Genetics and Genomics of Primary Biliary Cirrhosis
21. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants
22. DNA methylation profile of liver tissue in end-stage cholestatic liver disease.
23. Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.
24. Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581]
25. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants
26. HLA associations in small-duct compared with largeduct primary sclerosing cholangitis: 2029
27. Gene-Environment Interaction Identifies 3 Novel Loci Significantly Associated with Smoking and Family History in Primary Biliary Cirrhosis: 219
28. The AmpliChip CYP450 Test: Principles, Challenges, and Future Clinical Utility in Digestive Disease
29. Genetics of Hepatobiliary Diseases
30. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis
31. Genomics in the Post-GWAS Era
32. Carriage of a Tumor Necrosis Factor Polymorphism Amplifies the Cytotoxic T-Lymphocyte Antigen 4 Attributed Risk of Primary Biliary Cirrhosis: Evidence for a Gene–Gene Interaction
33. Common Genetic Variation and Haplotypes of the Anion Exchanger SLC4A2 in Primary Biliary Cirrhosis
34. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis
35. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis
36. Applying Genomics to the Study of Complex Disease
37. Genomics and complex liver disease: Challenges and opportunities
38. Is the FXR the Fix for Cholesterol Gallstone Disease?*
39. Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.
40. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
41. Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.
42. Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.
43. Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.
44. GWAS in Primary Biliary Cirrhosis
45. External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.
46. Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis
47. Low incidence of primary biliary cirrhosis ( PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.
48. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.
49. Mo1507: PLASMA BILE ACID PROFILES OF IBD PATIENTS FROM A WELL CHARACTERIZED PSC COHORT.
50. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different fromlarge duct disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.